These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15779350)

  • 1. [The internal and external cohort studies about impaired glucose tolerance].
    Shibazaki S; Nagai M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():82-6. PubMed ID: 15779350
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathophysiological conditions progressing from impaired glucose tolerance: type 2 diabetes mellitus].
    Asakura T; Ito Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():237-41. PubMed ID: 15779378
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetes prevention program (metformin)].
    Kusaka I; Nagasaka S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():471-7. PubMed ID: 15779424
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diet therapy for impaired glucose tolerance].
    Ogura M; Seino Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():503-8. PubMed ID: 15779430
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathophysiological conditions progressing from impaired glucose tolerance: coronary artery disease (ischemic heart disease)].
    Tomono S; Uchiyama T; Ohyama Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():255-9. PubMed ID: 15779382
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment for patients with impaired glucose tolerance].
    Tawaramoto K; Kaku K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired glucose tolerance: obesity and inactivity as modifiable risk factors.
    Taylor K
    Adv Nurse Pract; 2001 Dec; 9(12):59-61. PubMed ID: 12400355
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of health-risk appraisal in impaired glucose tolerance].
    Sakane N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():614-9. PubMed ID: 15779449
    [No Abstract]   [Full Text] [Related]  

  • 9. [The prevalence of impaired glucose tolerance in life-style related disease].
    Tomono S; Utsugi T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():78-81. PubMed ID: 15779349
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Inquiries: How can we keep impaired glucose tolerance and impaired fasting glucose from progressing to diabetes?
    Swanson A; Watrin K; Wilder L
    J Fam Pract; 2010 Sep; 59(9):532-3. PubMed ID: 20824232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiologic investigation on the incidence of diabetes mellitus from impaired glucose tolerance in population based study].
    Oizumi T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():73-7. PubMed ID: 15779348
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristic of metformin for treatment of impaired glucose tolerance].
    Ishida W; Satoh J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular risk factors in the Lublin Region population with and without type-2 diabetes mellitus.
    Mardarowicz G; Lopatyński J; Szcześniak G
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):471-7. PubMed ID: 15323239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of IGT education program at a hospital and its primary prevention effect on diabetes mellitus].
    Nunoi K; Fukui T; Sato Y; Sakuragi R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():582-7. PubMed ID: 15779444
    [No Abstract]   [Full Text] [Related]  

  • 15. STOP-NIDDM: a new paradigm for diabetes prevention?
    Hanefeld M
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):253-8. PubMed ID: 12616804
    [No Abstract]   [Full Text] [Related]  

  • 16. [Japan Diabetes Prevention Program].
    Sakane N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():488-92. PubMed ID: 15779427
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathophysiological conditions progressing from impaired glucose tolerance: high blood pressure].
    Katayama S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():242-5. PubMed ID: 15779379
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Study TO Prevent Non-Insulin Dependent Diabetes Mellitus trial (acarbose)].
    Nishimura R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():478-82. PubMed ID: 15779425
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prospective population survey of IGT in a Japanese community, Hisayama].
    Kiyohara Y; Fujishima M
    Nihon Rinsho; 1996 Oct; 54(10):2755-60. PubMed ID: 8914440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic campaign in Toyama: framework and program for organized cooperation in regional diabetes care and prevention].
    Fujikawa M; Kano B; Shiiba S; Kobayashi M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():565-77. PubMed ID: 15779442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.